Astral reviews demerger scheme 10 days after board approval
A big-four adviser will evaluate the plan within 30 days after stakeholder feedback. The future of the restructuring is uncertain.
— 3 earlier stories on Astral Ltd. →What's new
- Astral's board ordered an independent review of the demerger scheme on July 5, just 10 days after approval.
- A big-four adviser will evaluate the plan and submit recommendations within 30 days.
- The board will then decide whether to continue, modify, defer, or scrap the scheme.
Why this matters
The market had priced in the demerger as a settled value-unlocking event. This review introduces significant execution risk and timeline uncertainty, especially for a stock trading at 74x earnings where such catalysts matter.
What we're watching
- Whether the adviser recommends changes to the scheme structure or timeline.
- Management's next communication after the 30-day review period.
- Any impact on the stock price given the high valuation and uncertain deal outlook.
The full read
Astral's board approved a composite scheme of arrangement on June 25 to demerge its adhesives and chemicals business and merge Al-Aziz Plastics into Astral. Just 10 days later, on July 5, it ordered a review of the same plan after feedback from unnamed stakeholders, a swift reversal of course. A big-four adviser will now scrutinise the deal and report back within 30 days. Only then will the board decide: continue, modify, defer, or scrap the restructuring entirely. For a move the market had already priced as a settled catalyst, this is a sharp reversal. That the board acted so quickly suggests the pushback was serious. At 74x trailing earnings, Astral's valuation leaves little margin for error. The terms and timing of the demerger are now uncertain, and that uncertainty hurts.
Questions answered
- What prompted Astral to order the review?
- Unnamed stakeholder feedback raised concerns about the composite scheme of arrangement approved on June 25, leading the board to seek an independent assessment.
- What does the scheme involve?
- The scheme would demerge Astral's adhesives and construction chemicals business into Astral Chemie and merge Al-Aziz Plastics into Astral.
- What are the possible outcomes of the review?
- The board may continue, modify, defer, or drop the scheme entirely after considering the adviser's recommendations.
- Who is conducting the review?
- An external adviser from a big-four or equivalent firm, to be appointed and submit findings within 30 days.
- How does this affect the original timeline?
- The review period adds at least 30 days before the board decides the next steps, pushing back any implementation.
Astral Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on ASTRAL →- 5 Jul 2026 · 2:59 PM IST Astral reviews demerger scheme 10 days after board approval
- 7d ago Astral drops unified-brand strategy, CPVC plant on track for Q1 FY27
- 30d ago Astral's PEX pipe launch slips to September, CPVC plant to Q4 FY27
- 32d ago Astral lines up 51 institutional desks for June 8 meet